BOSTON--(BUSINESS WIRE)--May 9, 2019--
Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune
therapeutics company, today announced that the company will participate
in two upcoming healthcare conferences taking place in New York City
On Thursday, May 16, 2019, members of Gamida Cell’s management team will
participate in investor meetings at the Oppenheimer & Co. Oncology
Additionally, Julian Adams, Ph.D., chief executive officer of Gamida
Cell, will participate in a “fireside chat” at the RBC Capital Markets
Global Healthcare Conference on Tuesday, May 21, 2019, at 11:00 a.m. ET.
A live webcast of the presentation will be available on the Investors
section of the Gamida Cell website, www.gamida-cell.com.
About Gamida Cell
Gamida Cell is a clinical-stage
biopharmaceutical company committed to developing advanced cell
therapies with the potential to cure blood cancers and rare, serious
hematologic diseases. We are leveraging our proprietary
nicotinamide-based, or NAM-based, cell expansion technology to develop
product candidates designed to address the limitations of cell
therapies. For additional information, please visit www.gamida-cell.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190509005112/en/
Source: Gamida Cell Ltd.
Jaren Irene Madden
Krystle Gibbs (media)